- Home
- / Lepu Biopharma
Lepu Biopharma
Stock Price
$3.1
2024-10-29
Market Capitalization
$5.2 B
2024-10-29
Revenue
¥934.9 M
FY, 2025
Lepu Biopharma Summary
Company Summary
- Overview
- Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics. It develops a pipeline of drug candidates including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- HK | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Hong Kong Island HQ
Hong Kong
183 Queen's Rd E, Wan Chai
Lepu Biopharma Financials
Summary Financials
- Revenue (FY, 2025)
- ¥934.9M
- Gross profit (FY, 2025)
- ¥852.5M
- Net income (FY, 2025)
- ¥258.9M
- Cash (FY, 2025)
- ¥853.0M
- EBIT (FY, 2025)
- ¥19.8M
- Enterprise value
- $5.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026